Expert Insights on Current Treatments for Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to Progress
Alexander H Shannon, Samantha M Ruff, Timothy M Pawlik Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USACorrespondence: Timothy M Pawlik, Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, Pro...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-12-01
|
| Series: | Journal of Hepatocellular Carcinoma |
| Subjects: | |
| Online Access: | https://www.dovepress.com/expert-insights-on-current-treatments-for-hepatocellular-carcinoma-cli-peer-reviewed-fulltext-article-JHC |
| _version_ | 1797980654353252352 |
|---|---|
| author | Shannon AH Ruff SM Pawlik TM |
| author_facet | Shannon AH Ruff SM Pawlik TM |
| author_sort | Shannon AH |
| collection | DOAJ |
| description | Alexander H Shannon, Samantha M Ruff, Timothy M Pawlik Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USACorrespondence: Timothy M Pawlik, Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, Professor of Surgery, Oncology, Health Services Management and Policy, The Ohio State University, Wexner Medical Center, 395 W. 12th Ave., Suite 670, Columbus, OH, USA, Tel +1 614 293 8701, Fax +1 614 293 4063, Email Tim.Pawlik@osumc.eduAbstract: Hepatocellular carcinoma (HCC) is a primary liver tumor that typically occurs in the setting of chronic liver disease/cirrhosis. Treatment modalities for HCC have evolved and given the variety of treatment options, a multi-disciplinary approach requiring input from surgical, medical, and radiation oncology, hepatology, and interventional radiology is necessary. Multiple advances have been made over the last decade regarding treatment of HCC, especially advanced disease. Resection and transplantation remain as cornerstone curative-intent treatment options. For patients who are not candidates for curative-intent therapy, exciting progress has been made in molecular and cellular approaches to systemic therapy for HCC including immunotherapies and tyrosine kinase inhibitors. Although the prognosis for advanced HCC remains poor, the armamentarium of therapies has increased, and valuable years of life can be gained with these therapies. While the main therapeutic modality for early-stage disease remains resection, multimodal immunotherapy has emerged as first-line treatment for advanced disease. We herein review different clinical and molecular treatment modalities related to the treatment of HCC, as well as provide insights into future directions for HCC treatment. We highlight how research and progress are needed to move into a new era of molecular and cellular treatments.Keywords: hepatocellular carcinoma, current treatments |
| first_indexed | 2024-04-11T05:58:17Z |
| format | Article |
| id | doaj.art-175b77861d5b4696b4665b8e13feec62 |
| institution | Directory Open Access Journal |
| issn | 2253-5969 |
| language | English |
| last_indexed | 2024-04-11T05:58:17Z |
| publishDate | 2022-12-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Journal of Hepatocellular Carcinoma |
| spelling | doaj.art-175b77861d5b4696b4665b8e13feec622022-12-22T04:41:49ZengDove Medical PressJournal of Hepatocellular Carcinoma2253-59692022-12-01Volume 91247126180174Expert Insights on Current Treatments for Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to ProgressShannon AHRuff SMPawlik TMAlexander H Shannon, Samantha M Ruff, Timothy M Pawlik Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USACorrespondence: Timothy M Pawlik, Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, Professor of Surgery, Oncology, Health Services Management and Policy, The Ohio State University, Wexner Medical Center, 395 W. 12th Ave., Suite 670, Columbus, OH, USA, Tel +1 614 293 8701, Fax +1 614 293 4063, Email Tim.Pawlik@osumc.eduAbstract: Hepatocellular carcinoma (HCC) is a primary liver tumor that typically occurs in the setting of chronic liver disease/cirrhosis. Treatment modalities for HCC have evolved and given the variety of treatment options, a multi-disciplinary approach requiring input from surgical, medical, and radiation oncology, hepatology, and interventional radiology is necessary. Multiple advances have been made over the last decade regarding treatment of HCC, especially advanced disease. Resection and transplantation remain as cornerstone curative-intent treatment options. For patients who are not candidates for curative-intent therapy, exciting progress has been made in molecular and cellular approaches to systemic therapy for HCC including immunotherapies and tyrosine kinase inhibitors. Although the prognosis for advanced HCC remains poor, the armamentarium of therapies has increased, and valuable years of life can be gained with these therapies. While the main therapeutic modality for early-stage disease remains resection, multimodal immunotherapy has emerged as first-line treatment for advanced disease. We herein review different clinical and molecular treatment modalities related to the treatment of HCC, as well as provide insights into future directions for HCC treatment. We highlight how research and progress are needed to move into a new era of molecular and cellular treatments.Keywords: hepatocellular carcinoma, current treatmentshttps://www.dovepress.com/expert-insights-on-current-treatments-for-hepatocellular-carcinoma-cli-peer-reviewed-fulltext-article-JHChepatocellular carcinomacurrent treatments |
| spellingShingle | Shannon AH Ruff SM Pawlik TM Expert Insights on Current Treatments for Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to Progress Journal of Hepatocellular Carcinoma hepatocellular carcinoma current treatments |
| title | Expert Insights on Current Treatments for Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to Progress |
| title_full | Expert Insights on Current Treatments for Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to Progress |
| title_fullStr | Expert Insights on Current Treatments for Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to Progress |
| title_full_unstemmed | Expert Insights on Current Treatments for Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to Progress |
| title_short | Expert Insights on Current Treatments for Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to Progress |
| title_sort | expert insights on current treatments for hepatocellular carcinoma clinical and molecular approaches and bottlenecks to progress |
| topic | hepatocellular carcinoma current treatments |
| url | https://www.dovepress.com/expert-insights-on-current-treatments-for-hepatocellular-carcinoma-cli-peer-reviewed-fulltext-article-JHC |
| work_keys_str_mv | AT shannonah expertinsightsoncurrenttreatmentsforhepatocellularcarcinomaclinicalandmolecularapproachesandbottleneckstoprogress AT ruffsm expertinsightsoncurrenttreatmentsforhepatocellularcarcinomaclinicalandmolecularapproachesandbottleneckstoprogress AT pawliktm expertinsightsoncurrenttreatmentsforhepatocellularcarcinomaclinicalandmolecularapproachesandbottleneckstoprogress |